company background image
688382 logo

InventisBio SHSE:688382 Stock Report

Last Price

CN¥17.95

Market Cap

CN¥10.4b

7D

-3.5%

1Y

49.7%

Updated

17 Mar, 2025

Data

Company Financials +

InventisBio Co., Limited

SHSE:688382 Stock Report

Market Cap: CN¥10.4b

688382 Stock Overview

A clinical stage biotech company, engages in the discovery and development of therapeutics for cancer and metabolic diseases in China and the United States. More details

688382 fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance0/6
Financial Health4/6
Dividends0/6

Community vs My Fair Value

Create Narrative

Select a narrative for quick price alerts from the community, or create your own.

InventisBio Co., Limited Competitors

Price History & Performance

Summary of share price highs, lows and changes for InventisBio
Historical stock prices
Current Share PriceCN¥17.95
52 Week HighCN¥18.96
52 Week LowCN¥6.50
Beta0.28
1 Month Change39.47%
3 Month Change41.45%
1 Year Change49.71%
3 Year Changen/a
5 Year Changen/a
Change since IPO17.40%

Recent News & Updates

We're Hopeful That InventisBio (SHSE:688382) Will Use Its Cash Wisely

Dec 24
We're Hopeful That InventisBio (SHSE:688382) Will Use Its Cash Wisely

Recent updates

We're Hopeful That InventisBio (SHSE:688382) Will Use Its Cash Wisely

Dec 24
We're Hopeful That InventisBio (SHSE:688382) Will Use Its Cash Wisely

Companies Like InventisBio (SHSE:688382) Can Afford To Invest In Growth

Aug 07
Companies Like InventisBio (SHSE:688382) Can Afford To Invest In Growth

Are Investors Undervaluing InventisBio Co., Limited (SHSE:688382) By 22%?

May 23
Are Investors Undervaluing InventisBio Co., Limited (SHSE:688382) By 22%?

Shareholder Returns

688382CN BiotechsCN Market
7D-3.5%1.7%1.5%
1Y49.7%-12.8%13.9%

Return vs Industry: 688382 exceeded the CN Biotechs industry which returned -12.8% over the past year.

Return vs Market: 688382 exceeded the CN Market which returned 13.9% over the past year.

Price Volatility

Is 688382's price volatile compared to industry and market?
688382 volatility
688382 Average Weekly Movement8.4%
Biotechs Industry Average Movement5.5%
Market Average Movement6.1%
10% most volatile stocks in CN Market10.3%
10% least volatile stocks in CN Market3.5%

Stable Share Price: 688382's share price has been volatile over the past 3 months compared to the CN market.

Volatility Over Time: 688382's weekly volatility (8%) has been stable over the past year, but is still higher than 75% of CN stocks.

About the Company

FoundedEmployeesCEOWebsite
2013188Yaolin Wangwww.inventisbio.com

InventisBio Co., Limited, a clinical stage biotech company, engages in the discovery and development of therapeutics for cancer and metabolic diseases in China and the United States. The company’s drug candidates for the oncology therapeutic area include BPI-D0316, which is in Phase III clinical trial for the non-small cell lung cancer (NSCLS) indications; D-0502, which is in Phase I clinical trial for the breast cancer indications; and D-1553, which in Phase I clinical trial for NSCLS, colorectal cancer indications. Its drug candidates for the metabolic therapeutic area is D-0120, a Phase I and II clinical trial product for hyperuricemia and gout indications.

InventisBio Co., Limited Fundamentals Summary

How do InventisBio's earnings and revenue compare to its market cap?
688382 fundamental statistics
Market capCN¥10.35b
Earnings (TTM)-CN¥245.62m
Revenue (TTM)CN¥169.10m

61.2x

P/S Ratio

-42.1x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
688382 income statement (TTM)
RevenueCN¥169.10m
Cost of RevenueCN¥0
Gross ProfitCN¥169.10m
Other ExpensesCN¥414.73m
Earnings-CN¥245.62m

Last Reported Earnings

Dec 31, 2024

Next Earnings Date

Apr 26, 2025

Earnings per share (EPS)-0.43
Gross Margin100.00%
Net Profit Margin-145.25%
Debt/Equity Ratio1.4%

How did 688382 perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/03/17 01:30
End of Day Share Price 2025/03/17 00:00
Earnings2024/12/31
Annual Earnings2024/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

InventisBio Co., Limited is covered by 6 analysts. 3 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ziyu HeChina International Capital Corporation Limited
Xiaoyi QuChina International Capital Corporation Limited
Shitong HanCitic Securities Co., Ltd.